REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $958,000 | +447.4% | 49,123 | +358.8% | 0.01% | +400.0% |
Q4 2021 | $175,000 | -88.6% | 10,707 | -78.6% | 0.00% | -83.3% |
Q1 2018 | $1,538,000 | +15280.0% | 49,934 | +12670.8% | 0.01% | – |
Q2 2017 | $10,000 | -82.5% | 391 | -77.9% | 0.00% | – |
Q2 2015 | $57,000 | -95.5% | 1,771 | -95.2% | 0.00% | -100.0% |
Q2 2014 | $1,262,000 | +3.9% | 37,118 | -3.8% | 0.01% | 0.0% |
Q1 2014 | $1,215,000 | – | 38,573 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |